News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
825,154 Results
Type
Article (85319)
Company Profile (624)
Press Release (739211)
Section
Business (231924)
Career Advice (4093)
Deals (39626)
Drug Delivery (107)
Drug Development (90479)
Employer Resources (192)
FDA (17906)
Job Trends (17249)
News (394780)
Policy (39595)
Tag
Academia (2974)
Africa (1263)
Alliances (56354)
Alzheimer's disease (1253)
Approvals (17822)
Arizona (210)
Artificial intelligence (91)
Asia (49043)
Australia (8623)
Bankruptcy (392)
Best Places to Work (12290)
Biotechnology (440)
C2C Services and Suppliers (95111)
California (2144)
Canada (986)
Cancer (594)
Career advice (3500)
Cell therapy (154)
China (168)
Clinical research (70569)
Collaboration (179)
Colorado (90)
Compensation (89)
Connecticut (91)
COVID-19 (2760)
Cystic fibrosis (79)
Data (401)
Diabetes (99)
Diagnostics (6512)
Drug pricing (93)
Earnings (93551)
Employer resources (162)
Europe (112156)
Events (125145)
Executive appointments (176)
FDA (18179)
Florida (293)
Funding (175)
Gene therapy (114)
GLP-1 (629)
Government (5019)
Healthcare (20660)
Hotbed/Location (534575)
Illinois (330)
Indiana (167)
Infectious disease (2799)
Inflammatory bowel disease (104)
Interviews (805)
IPO (17500)
Job creations (5172)
Job search strategy (2851)
Kansas (100)
Layoffs (471)
Legal (10016)
Lung cancer (132)
Manufacturing (113)
Maryland (456)
Massachusetts (1805)
Medical device (14283)
Medtech (14288)
Mergers & acquisitions (21983)
Metabolic disorders (319)
Michigan (140)
Minnesota (241)
Neuroscience (1437)
New Jersey (652)
New York (652)
NextGen Class of 2024 (7624)
Non-profit (5054)
North Carolina (713)
Northern California (887)
Obesity (193)
Ohio (115)
Opinion (235)
Patents (85)
Pennsylvania (620)
People (63770)
Pharmaceutical (119)
Phase I (21659)
Phase II (30636)
Phase III (23154)
Pipeline (122)
Podcasts (78)
Policy (73)
Postmarket research (3535)
Preclinical (9782)
Radiopharmaceuticals (251)
Rare diseases (154)
Real estate (7365)
Regulatory (25658)
Research institute (2633)
Resumes & cover letters (646)
South America (1641)
Southern California (826)
Startups (4273)
Texas (284)
United States (9809)
Vaccines (579)
Washington State (287)
Weight loss (179)
Date
Today (96)
Last 7 days (526)
Last 30 days (2682)
Last 365 days (39657)
2024 (28818)
2023 (42566)
2022 (53929)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 825,154 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Schizophrenia
FDA Approves First Novel Schizophrenia Drug in 35 Years
First-in-class, BMS’ KarXT targets the M1 and M4 muscarinic receptors to reduce schizophrenia symptoms while also avoiding some of the symptoms associated with antipsychotics drugs.
September 26, 2024
·
7 min read
·
Heather McKenzie
Press Releases
CD137 As Emerging Target In Cancer Immunotherapy
September 26, 2024
·
1 min read
Venture capital
ARCH Fuels Up With $3B to Support Next Class of AI Biotechs
ARCH Venture Partners is the latest venture capital firm to raise a multi-billion-dollar fund. The cash will be used to support new startups working with AI.
September 26, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
U.S. Drug Discovery Outsourcing Market Size to Reach USD 3.44 Billion By 2033
September 26, 2024
·
1 min read
Career Advice
Telling the Right Story: Overselling, Underselling Can Hurt Your Candidacy
During the job application and interview process, candidates who lie to prospective employers and those who don’t properly highlight their accomplishments can find it difficult to land—or keep—their next role. We asked experts how to sell yourself positively and honestly.
September 26, 2024
·
5 min read
·
Angela Gabriel
Drug Development
AI Return on Investment: Just Because We Can, Should We?
In this episode, Lori and guests continue their exploratory discussion on AI and focus on the challenges of globalization and return on investment.
September 26, 2024
·
1 min read
·
Lori Ellis
Press Releases
American Aires to Present at CEM’s In-Person Muskoka Small-Cap Investor Conference on Sept. 28, 2024
September 26, 2024
·
5 min read
Press Releases
Nextleaf Announces the Appointment of Chief Executive Officer
September 26, 2024
·
5 min read
Collaboration
Novo, Evotec Ink Stem Cell Partnership as Drugmaker Looks to Expand Pipeline
While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites in Germany and Italy to support the development of next-generation cell therapies.
September 26, 2024
·
2 min read
·
Tristan Manalac
Sickle cell disease
Pfizer Takes Sickle Cell Drug Oxbryta Off Global Market, Cites Risk of Death
Based on new safety signals, Pfizer on Wednesday announced that Oxbryta’s overall benefit “no longer outweighs the risk” in patients with sickle cell disease. Guggenheim Securities analysts said the setback increases investor frustrations with the company’s business development track record.
September 26, 2024
·
2 min read
·
Tristan Manalac
1 of 82,516
Next
